Zyprexa (Olanzapine)

📧 EM Note Newsletter https://forms.gle/8boToiKDXVE3V8U19 Signup to get free weekly PDF via email. PS: Please join our membership for more perks (members can request for specific PDF file by posting in the EM Note YouTube Membership section). Homepage: EMNote.org ■ 🚩Membership: https://tinyurl.com/joinemnote 🚩ACLS Lecture: https://tinyurl.com/emnoteacls Zyprexa or olanzapine is an FDA-approved antipsychotic used for managing schizophrenia and various phases of bipolar disorder. The lecture highlights a range of available formulations, including standard tablets and long-acting injections, while outlining precise dosing protocols for different age groups. Significant attention is given to serious safety warnings, such as the risk of metabolic syndrome, weight gain, and increased mortality in elderly patients with dementia. Furthermore, the text addresses clinical controversies regarding the drug's long-term side effects and the specific monitoring requirements necessary for its more restrictive administration methods. Ultimately, the document provides a balanced overview of the medication’s therapeutic efficacy against its potentially severe neurological and cardiovascular risks.